CClinicalTrials.gg
Not yet recruitingNCT07864597Updated Oct 8, 2026

Family Physician Nudges for Influenza Vaccination Among Older Adults

An interventional study of Family Physician Influenza Vaccination Nudge in Influenza Vaccination, sponsored by Fudan University. Not yet recruiting. Open to participants aged 55 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Fudan University · Not applicable, Interventional, and Health services research

Updated Oct 8, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
5,250
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if a family-physician nudge intervention works to improve influenza vaccination among adults aged 55 years and older in China. Three independent, parallel cluster randomized controlled trials will be conducted under three distinct vaccine payment policies, i.e. free vaccination for those older than 65 years and self-paid vaccination for those \<65 years in rural areas, and partially insurance-covered vaccination in urban areas.

The main questions it aims to answer are:

  1. Does the family-physician nudge intervention increase influenza vaccination uptake among older adults? How does the effectiveness of the nudge intervention vary under different payment policies?
  2. Is the family-physician nudge intervention cost-effective, acceptable, feasible, and potentially sustainable in primary care settings? Researchers will compare an intervention group receiving a family-physician nudge with a control group receiving routine care to see if the nudge is effective at increasing influenza vaccination among older adults.

Participants will:

  1. Be recruited at community health service centers and cluster-randomized by their family physicians into one of two groups.
  2. Receive either a physician nudge (provider recommendation by an endowment-framing educational pamphlet + default appointment + a follow-up reminder) or routine health education.
  3. Have their influenza vaccination status verified through the immunization information system at the end of the trial.
Read the detailed description

Influenza vaccination is the most effective measure for preventing influenza. However, the influenza vaccination rate in China is extremely low, with older adults, a high-risk group for influenza, having a vaccination rate of only about 4%. Beginning in 2026, China provides free influenza vaccination for adults aged 65 years and older in rural areas, and allows the personal accounts of employees' basic medical insurance to be used to pay for influenza vaccination for the account holders and their family members, thereby removing the economic barrier to vaccination. Under these payment policies, how to design effective behavioral intervention strategies to increase the vaccination rate has become an important issue.

This study proposes to conduct three independent, parallel cluster randomized controlled trials to implement a family-physician influenza vaccination nudge intervention among adults aged 55 years and older, and to evaluate the effect of the intervention on improving the influenza vaccination rate among older adults under three distinct payment policies. The three sub-trials are conducted under the free vaccination policy for adults aged 65 years and older in rural areas, the self-paid vaccination policy for adults aged 55-64 years in rural areas, and the partially insurance-covered vaccination policy for adults aged 55 years and older in urban areas, respectively. A health economic evaluation will be conducted concurrently, together with a feasibility evaluation based on semi-structured interviews, so as to empower family physicians to promote vaccination among older populations.

Sample sizes are calculated independently for the three sub-trials, based on the primary outcome measure (influenza vaccination uptake) and the main analysis method (comparison of rates between two groups). For the rural sub-trial (free-vaccine policy), taking 10% vaccination rate as the control-group baseline and assuming the nudge intervention raises the rate to 18% (an 8-percentage-point absolute increase), with α = 0.05 (two-sided) and ICC = 0.02, an average of 20 participants per cluster and 54 clusters (family physicians) are required to achieve the power of 90%, resulting in a total sample of 1,080 adults aged 65 years and older. For the rural sub-trial (out-of-pocket policy), taking 4% vaccination rate as the control-group baseline and assuming the intervention raises the rate to 8% (a 4-percentage-point increase, attenuated by economic factors), with the same α and ICC, and an average of 43 participants per cluster and 54 clusters (family physicians) are required to achieve the power of 85%, resulting in a total sample of 2,322 adults aged 55-64 years. For the urban sub-trial (out-of-pocket/insurance policy), taking 5% vaccination rate as the control-group baseline and assuming the intervention raises the rate to 10% (a 5-percentage-point increase, attenuated by economic factors), with the same α and ICC, and an average of 44 participants per cluster and 42 clusters (family physicians) are required to achieve the power of 85%, resulting in a total sample of 1,848 adults aged 55 years and older.

A cluster randomized controlled design will be employed across three representative regions in China. Taking the level of economic development into account, three provinces are selected from the eastern, central, and western regions, and in each province, 3-4 community health service centers (CHCs) are selected in urban and rural areas respectively. In total, 9-12 urban/rural CHCs are recruited, yielding approximately 42 urban and 54 rural family physician clusters. Older adults will be recruited during the primary care visits at the participating CHCs, where all eligible patients meeting inclusion criteria are invited to participate and provide informed consent.

Randomization is performed independently for each sub-trial, with the family physician as the cluster unit. The randomization sequence will be generated in advance by an independent statistician using a computer-generated random number method. Owing to the nature of the intervention, both family physicians and participants are aware of group assignment, and blinding cannot be fully implemented; however, local coordinators, outcome assessors, data managers, and statistical analysts are blinded to group allocation.

The intervention group receives a three-component nudge: (1) an endowment-framing educational pamphlet and verbal recommendation for influenza vaccination by the family physician; (2) on-site default appointment (opt-out) for vaccination; and (3) a telephone reminder at two weeks for those not yet vaccinated. The control group maintains the existing routine service model, with only standard influenza vaccination health education provided during routine encounters.

The intention-to-treat (ITT) approach is used as the primary analysis strategy. Influenza vaccination status at 1 month and 3 months is analyzed using generalized estimating equations (GEE) with the family physician as the clustering unit and the community health service center as a fixed effect, adjusting for prespecified covariates (region, sex, age, marital status, type of medical insurance in the urban sub-trial, and prior influenza vaccination history). Adjusted relative risk and absolute risk difference with 95% confidence intervals are reported. Time-to-vaccination is evaluated using Kaplan-Meier curves and Cox proportional hazards models with robust standard errors. Prespecified subgroup analyses assess heterogeneity of intervention effects. A per-protocol analysis serves as a sensitivity analysis. A health economic evaluation (cost-effectiveness with ICER calculation) and a feasibility evaluation via semi-structured interviews with family physicians and older adults are conducted alongside the trial.

02

Conditions studied

  • Influenza Vaccination

Browse trials for

Keywords

  • influenza vaccination
  • nudge
  • family physician
  • clinical trial
  • older adults
  • behavioral science
03

In context

Influenza, Human

2,214 studies on the registry are indexed under Influenza, Human; 163 are open to participants now.

This study's planned enrollment of 5,250 is above the median of 238 across 1,853 interventional studies indexed under Influenza, Human.

Browse Influenza, Human studies →

Lead sponsor

Fudan University is the lead sponsor of 1,271 studies on the registry; 624 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age ≥ 55 years.
  • Not vaccinated against influenza in the current flu season.
  • No contraindications to influenza vaccination.
  • Willing and able to provide informed consent and participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Age under 55 years.
  • Has already received influenza vaccination in the current flu season.
  • Has a known contraindication to influenza vaccination.
  • Unable to comply with study procedures.
  • Unwilling or unable to provide informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
5,250 participants (estimated)

Study arms

  • Experimental
    Family Physician Nudge Group

    In addition to routine health education, participants in this arm receive a multicomponent nudge delivered by their family physician during a routine primary care encounter. The nudge consists of: (1) an endowment-framing educational pamphlet and verbal recommendation for influenza vaccination by the family physician; (2) on-site assistance with scheduling a vaccination appointment as the default (opt-out) option; and (3) a telephone reminder two weeks after the encounter for those who have not yet completed vaccination. The intervention is delivered during the 2026-2027 influenza vaccination season.

    Behavioral: Family Physician Influenza Vaccination Nudge

  • No intervention
    Routine Care Group

    Participants assigned to the control arm receive routine care - the family physician sees them per standard clinical procedures and provides only routine health education on influenza vaccination, without the deliberate use of the nudge intervention components (no structured recommendation, no default appointment, no two-week telephone reminder).

Interventions

  • BehavioralFamily Physician Influenza Vaccination Nudge

    A family-physician-delivered behavioral nudge combines provider recommendation by an endowment-framing educational pamphlet, default appointment scheduling, and a follow-up reminder, which is designed to increase influenza vaccination uptake among older adults. Grounded in behavioral science theories of vaccination decision-making and nudging, the intervention leverages the high credibility of primary-care family physicians among older adults and reduces the behavioral frictions associated with seeking vaccination.

06

What researchers measure

Primary outcomes

  1. Influenza Vaccination Uptake

    Whether participants get vaccinated against influenza, measured by official vaccination records.

    Time frame: 1 month and 3 months after the intervention

Secondary outcomes

  1. Timing of Influenza Vaccination

    Number of days from the intervention date to receipt of influenza vaccination, measured by official vaccination records.

    Time frame: Within 3 months after the intervention

Other outcomes

  1. Spouse Influenza Vaccination Uptake

    Whether the participant's spouse gets vaccinated against influenza, measured by official vaccination records.

    Time frame: 1 month and 3 months after the intervention

  2. Timing of Spouse Influenza Vaccination

    Number of days from the participant's intervention date to spouse's influenza vaccination, measured by official vaccination records.

    Time frame: Within 3 months after the intervention

  3. Incremental Cost-Effectiveness Ratio (ICER)

    Cost per additional vaccinated person and cost per additional quality-adjusted life year (QALY) gained, calculated from both health-system and societal perspectives using micro-costing data. QALYs projected over annual horizon.

    Time frame: Within 3 months after the intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Mehta SJ, Waddell KJ, Linn KA, Brophy C, Liang J, Park SH, Reitz C, Williams K, Couzens C, Staloff J, White AA, Rhodes C, Liao JM, Navathe AS. Nudges to Clinicians and Patients for Influenza Vaccines During Visits: The BE IMMUNE Randomized Clinical Trial. JAMA Intern Med. 2026 Mar 1;186(3):304-310. doi: 10.1001/jamainternmed.2025.7133. PubMed 41490010 ↗
  • Cao Y, Wang Q, Zhao J, Zhang Y, Huo R, Li Q, Yang W, Yi H, Feng L. Healthcare workers' attitudes toward influenza vaccine prescriptions in China. Glob Health Res Policy. 2025 Aug 4;10(1):34. doi: 10.1186/s41256-025-00430-0. PubMed 40760695 ↗
  • Kim RH, Day SC, Small DS, Snider CK, Rareshide CAL, Patel MS. Variations in Influenza Vaccination by Clinic Appointment Time and an Active Choice Intervention in the Electronic Health Record to Increase Influenza Vaccination. JAMA Netw Open. 2018 Sep 7;1(5):e181770. doi: 10.1001/jamanetworkopen.2018.1770. PubMed 30646151 ↗
  • Lehmann BA, Chapman GB, Franssen FM, Kok G, Ruiter RA. Changing the default to promote influenza vaccination among health care workers. Vaccine. 2016 Mar 8;34(11):1389-92. doi: 10.1016/j.vaccine.2016.01.046. Epub 2016 Feb 3. PubMed 26851734 ↗
  • Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong JYT, Yang J, Bond HS, Wang L, Lau YC, Zheng J, Feng S, Qin Y, Fang VJ, Jiang H, Lau EHY, Liu S, Qi J, Zhang J, Yang J, He Y, Zhou M, Cowling BJ, Feng L, Yu H. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019 Sep;4(9):e473-e481. doi: 10.1016/S2468-2667(19)30163-X. PubMed 31493844 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared due to participant privacy concerns and institutional data protection policies. Aggregate study results will be published in peer-reviewed journals and disseminated through policy briefs.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 8, 2026
Show all 1 update
  1. Oct 8, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07864597
Lead sponsor
Fudan University
Responsible party
Zhiyuan Hou (Associate Professor, Fudan University) — Principal investigator
First posted
Oct 8, 2026
Start date
Oct 8, 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Oct 8, 2026

Study contacts

Zhiyuan Hou, PhD
Contact
zyhou@fudan.edu.cn
86+21 54231112

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion